Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOWe need to determine if management conveys that successive engagements of the same kind are coming in at progressively larger size. The question asks about unit size escalation: deals, orders, contracts, projects, customers, sites, programs landing now are individually bigger, broader, or longer than before. We need to look for management's own words describing a comparison against their own recent past, already real and recurring, and early (not fully reflected yet). The transcript discusses growth in glasses, contacts, eye exams, stores, etc. But does it say that each new instance (e.g., each new store, each new customer, each new contract) is bigger than before? For example, are new stores generating more revenue per store than earlier stores? Or are new customers spending more at outset? Or are insurance contracts larger? Let's scan the transcript. Neil: "We continue to see strong adoption of higher priced frames and more complex lens types like precision progressives... Progressives overall still only represent approximately 22% of our prescription glasses sold in Q1, and we continue to believe there's a significant opportunity to increase penetration over time." That's about mix, not unit size escalation. Dave: "We continue to see positive customer retention metrics and repeat purchasing patterns across cohorts, including a revenue retention rate of roughly 50% over 24 months and roughly 100% over 48 months for the most recent cohort." That's about retention, not size. Steve: "We also continue to see strength in average revenue per customer of $296 in Q1, up 9.6% year-over-year. This was driven by a few factors, including an increase in higher priced lenses, including progressives and continued ramping of both contact lens and eye exam sales." That's average revenue per customer increasing, but that could be due to price increases or mix, not necessarily that each new customer is bigger. The question specifically asks about "successive engagements of the same kind" — e.g., each new store, each new customer, each new contract. Average revenue per customer increasing could be due to existing customers spending more, not new customers starting at a higher level. We need to see if management says that new customers are starting at a higher level or that new stores are performing better than earlier stores.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.